Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
|---|---|---|---|---|
Revenue | $22 | $0 | $0 | $0 |
Gross Profit | 22 | -3 | -3 | -3 |
EBITDA | -5,695 | -9,225 | -9,825 | -8,499 |
EBIT | -5,767 | -9,229 | -9,829 | -8,503 |
Net Income | -1,204 | 1,715 | -11,359 | 6,001 |
Net Change In Cash | 22 | 0 | 0 | 0 |
Free Cash Flow | -4,485 | -4,961 | -7,444 | -7,605 |
Cash | 862 | 933 | 6,206 | 13,645 |
Basic Shares | 16,454 | 15,981 | 15,981 | 16,674 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -82 | -15 | -15 | -15 |
EBITDA | -4,771 | -30,665 | -15,133 | -8,686 |
EBIT | -4,854 | -30,681 | -15,148 | -8,702 |
Net Income | -4,791 | -20,302 | -11,580 | -2,894 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -16,227 | |||
Free Cash Flow | -24,582 | -23,744 | -12,484 | -7,747 |
Cash | 862 | 21,251 | 41,041 | 57,268 |
Basic Shares | 16,454 | 15,619 | 15,494 | 4,519 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-07-31 | -$0.07 |
2024-04-30 | $0.11 |
2024-01-31 | -$0.71 |
2023-10-31 | -$0.50 |
